FDA Panel Weighs Historic Multi-Cancer Blood Test as Cancer Deaths Fall 35%

An independent FDA advisory committee votes today on whether to recommend Grail's Galleri blood test for approval — a single blood draw that screens for up to 50 forms of cancer simultaneously, a potentially transformative shift in how the disease is caught.

Plain English

Imagine a routine blood test at your annual checkup that could flag early signs of dozens of cancers before you ever feel sick. That's what Galleri promises. The FDA's advisory panel is meeting...